Allergan to Acquire Aesthetic Drug Maker for $2.1 Billion
Allergan and Kythera Biopharmaceuticals, a company focused on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market, announced that they have entered into a definitive agreement under which Allergan has agreed to acquire Kythera in a cash and equity transaction va...